Aug. 16 Financial Quick Takes: Trio of IPO filings; plus Bellicum, Generex

SpringWorks, Satsuma, Monopar propose IPOs
SpringWorks Therapeutics Inc. (Stamford, Conn.), Satsuma Pharmaceuticals Inc. (South San Francisco, Calif.) and Monopar Therapeutics Inc. (Northbrook, Ill.) are looking to go public on NASDAQ.

SpringWorks proposed to raise up to $115 million in its IPO, three months after raising a $125 million series B. The company is developing rare disease and cancer programs spun out of Pfizer Inc. (NYSE:PFE), with lead candidate nirogacestat in Phase III testing for desmoid tumors. SpringWorks’ shareholders include Pfizer, Bain, OrbiMed and Perceptive Life Sciences; underwriters are J.P. Morgan, Goldman Sachs, Cowen and Wedbush PacGrow. ...